Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ECULIZUMAB vs PEGCETACOPLAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ECULIZUMAB vs PEGCETACOPLAN: Safety Overview

Metric ECULIZUMAB PEGCETACOPLAN
Total FAERS Reports 44,190 1,369
Deaths Reported 4,626 84
Death Rate 10.5% 6.1%
Hospitalizations 12,421 252
Average Patient Age 42.6 yrs 65.4 yrs
% Female Patients 59.5% 70.5%
FDA Approval Date N/A Feb 17, 2023
Manufacturer Alexion Pharmaceuticals Inc. Apellis Pharmaceuticals, Inc.
Route INTRAVENOUS SUBCUTANEOUS
Marketing Status Prescription Prescription